If you can spare a few minutes, please help us improve our website by completing this survey.
In 2016, Mayo Clinic and the Koch Institute (KI) for Integrative Cancer Research at MIT launched a collaboration in the areas of cancer biology, therapeutic development, diagnosis, and treatment. This strategic relationship capitalizes on the basic and translational strengths of Mayo Clinic and the broad range of biological and technological expertise of the KI, and fosters joint approaches by engineers and cancer scientists, both basic and clinical/translational.
Led by faculty from both institutions, multidisciplinary teams will develop transformative solutions to address unmet clinical needs of cancer patients. As a mechanism to encourage collaboration, leaders from both institutions established a new research awards program in June 2016: the Mayo Clinic – Koch Institute Cancer Solutions Team Grant.
Information for Mayo Clinic & MIT faculty:
Three 3-year team grants were awarded in 2016.